Beigene Ltd (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BGNE Nasdaq 2834 https://www.beigene.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Beigene Ltd (ADR)

BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity - Mar 30th, 2023 11:00 am
Investing in BeiGene (NASDAQ:BGNE) three years ago would have delivered you a 75% gain - Mar 27th, 2023 10:25 am
J.P. Morgan Analysts Say These 2 Stocks Are Their Top Picks for 2023 - Mar 25th, 2023 6:53 pm
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey - Mar 21st, 2023 11:00 am
BeiGene Will Not Go Forward With Licensing Pact For Leap Therapeutics' Lead Cancer Candidate - Mar 17th, 2023 4:26 pm
Prelude (PRLD) Collaborates With BeiGene for Oncology Candidate - Mar 16th, 2023 4:06 pm
Tencent, Alibaba, AIA fuel Hong Kong market rally while BeiGene erases loss amid Silicon Valley Bank fallout - Mar 13th, 2023 9:30 am
HKMA monitoring Silicon Valley Bank fallout as Hong Kong-listed firms' exposure reaches US$217 million - Mar 13th, 2023 9:30 am
Q4 2022 Zymeworks Inc Earnings Call - Mar 8th, 2023 5:36 pm
11 Most Promising Cancer Stocks According to Analysts - Feb 28th, 2023 4:54 pm
Down -15.66% in 4 Weeks, Here's Why You Should You Buy the Dip in BeiGene, Ltd. (BGNE) - Feb 28th, 2023 2:35 pm
Here's Why BeiGene, Ltd. (BGNE) is Poised for a Turnaround After Losing -17.02% in 4 Weeks - Feb 27th, 2023 2:35 pm
BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results - Feb 27th, 2023 12:00 pm
12 High Growth Healthcare Stocks to Buy - Feb 26th, 2023 1:04 pm
BeiGene Receives 10th Approval for PD-1 Inhibitor Tislelizumab in China - Feb 24th, 2023 12:00 pm
BeiGene to Present at Cowen’s 43rd Annual Healthcare Conference - Feb 24th, 2023 12:00 pm
Is a Surprise Coming for BeiGene (BGNE) This Earnings Season? - Feb 23rd, 2023 1:34 pm
Down -14.15% in 4 Weeks, Here's Why BeiGene, Ltd. (BGNE) Looks Ripe for a Turnaround - Feb 22nd, 2023 2:35 pm
Is Apexigen, Inc. (APGN) Stock Outpacing Its Medical Peers This Year? - Feb 15th, 2023 2:40 pm
Quebec becomes first province to cover PrBRUKINSA® (zanubrutinib) for the Treatment of Waldenström's macroglobulinemia - Feb 6th, 2023 11:37 am